{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:59:44Z","timestamp":1787619584795,"version":"build-2736575974"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess the process and outcomes of academic detailing to enhance the Opioid Safety Initiative and the Psychotropic Drug Safety Initiative to reduce co-prescribing of opioid-benzodiazepine combinations in veterans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort design was conducted to evaluate the impact of implementing an academic detailing program on opioid-benzodiazepine co-prescribing between October 2014 through March 2019 at the U.S. Department of Veterans Affairs (VA). The primary outcome was the monthly prevalence of veterans (number per 1,000 population) who were co-prescribed opioid-benzodiazepine combination. Process measure was evaluated using implementation reach (proportion of providers who received academic detailing). Station-level analysis was performed using a linear fixed effects regression model to evaluate the rate of change in the prevalence of veterans co-prescribed opioid-benzodiazepine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Altogether 130 VA stations was included for analysis; 119 stations implemented opioid-related or benzodiazepine-related academic detailing, and 11 stations did not. Stations that had implemented academic detailing had a 33% greater monthly reduction on the opioid-benzodiazepine co-prescribing prevalence compared to stations that did not implement academic detailing (P\u2009=\u2009.036). In the linear fixed effects regression model, stations that were expected to have 100% of providers exposed to academic detailing were statistically associated with a greater decrease in the monthly prevalence of Veterans co-prescribed opioid-benzodiazepine by 4.9 veterans per 1,000 population (P\u2009&amp;lt;\u2009.001) compared to stations with 0% of providers exposed to academic detailing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Stations that implemented academic detailing and had a higher proportion of providers who were exposed to opioid- or benzodiazepine-related academic detailing had a significant decrease in the monthly prevalence of Veterans co-prescribed opioid-benzodiazepine combinations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/pm\/pnaa475","type":"journal-article","created":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T07:25:05Z","timestamp":1608362705000},"page":"1426-1434","source":"Crossref","is-referenced-by-count":13,"title":["Impact of Implementing an Academic Detailing Program on Opioid-Benzodiazepine Co-Prescribing Trends at the U.S. Department of Veterans Affairs"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7343-9458","authenticated-orcid":false,"given":"Mark","family":"Bounthavong","sequence":"first","affiliation":[{"name":"U.S. Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Academic Detailing Service, Washington, District of Columbia, USA"},{"name":"U.S. Department of Veterans Affairs (VA) Health Economics Resource Center, Menlo Park, California, USA"},{"name":"U.S. Department of Veterans Affairs (VA) Center for Innovation to Implementation, Menlo Park, California, USA"},{"name":"Division of Clinical Pharmacy, University of California San Diego, Skaggs School of Pharmacy & Pharmaceutical Sciences, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos K","family":"Lau","sequence":"additional","affiliation":[{"name":"U.S. Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Academic Detailing Service, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad L","family":"Kay","sequence":"additional","affiliation":[{"name":"U.S. Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Academic Detailing Service, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daina L","family":"Wells","sequence":"additional","affiliation":[{"name":"U.S. Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Academic Detailing Service, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J","family":"Popish","sequence":"additional","affiliation":[{"name":"U.S. Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Academic Detailing Service, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Harvey","sequence":"additional","affiliation":[{"name":"U.S. Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Academic Detailing Service, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne E","family":"Himstreet","sequence":"additional","affiliation":[{"name":"U.S. Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Academic Detailing Service, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Grana","sequence":"additional","affiliation":[{"name":"U.S. Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Academic Detailing Service, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake A","family":"Freeman","sequence":"additional","affiliation":[{"name":"U.S. Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Academic Detailing Service, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M","family":"Morillo","sequence":"additional","affiliation":[{"name":"U.S. Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Academic Detailing Service, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L D","family":"Christopher","sequence":"additional","affiliation":[{"name":"U.S. Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Academic Detailing Service, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"2021070821083838800_pnaa475-B1","year":"2019"},{"issue":"4","key":"2021070821083838800_pnaa475-B2","doi-asserted-by":"crossref","first-page":"e202361","DOI":"10.1001\/jamanetworkopen.2020.2361","article-title":"Alcohol or benzodiazepine co-involvement with opioid overdose deaths in the United States, 1999\u20132017","volume":"3","author":"Tori","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"2021070821083838800_pnaa475-B3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2017\u20132018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2021070821083838800_pnaa475-B4","first-page":"24","article-title":"Pharmacology of benzodiazepine receptors: An update","volume":"19","author":"Sieghart","year":"1994","journal-title":"J Psychiatry Neurosci"},{"issue":"6755","key":"2021070821083838800_pnaa475-B5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"issue":"13","key":"2021070821083838800_pnaa475-B6","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"7","key":"2021070821083838800_pnaa475-B7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/pme.12321","article-title":"Increased polysedative use in veterans with posttraumatic stress disorder","volume":"15","author":"Bernardy","year":"2014","journal-title":"Pain Med Malden Mass"},{"issue":"3","key":"2021070821083838800_pnaa475-B8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.pain.2010.08.002","article-title":"Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain","volume":"151","author":"Morasco","year":"2010","journal-title":"Pain"},{"issue":"9","key":"2021070821083838800_pnaa475-B9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/M18-0852","article-title":"Receipt of overlapping opioid and benzodiazepine prescriptions among veterans dually enrolled in Medicare part D and the Department of Veterans Affairs: A cross-sectional study","volume":"169","author":"Carico","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"2021070821083838800_pnaa475-B10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jamainternmed.2017.0147","article-title":"Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs","volume":"177","author":"Gellad","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"3","key":"2021070821083838800_pnaa475-B11","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.jagp.2016.02.026","article-title":"Improving psychopharmacological care for older veterans: implementation of phase 2 of the psychotropic drug safety initiative","volume":"24","author":"Wiechers","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"issue":"24","key":"2021070821083838800_pnaa475-B12","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM198306163082406","article-title":"Improving drug-therapy decisions through educational outreach: A randomized controlled trial of academically based \u201cdetailing.\u201d","volume":"308","author":"Avorn","year":"1983","journal-title":"N Engl J Med"},{"issue":"5","key":"2021070821083838800_pnaa475-B13","first-page":"66","article-title":"VA academic detailing service: Implementation and lessons learned","volume":"33","author":"Wells","year":"2016","journal-title":"Fed Pract"},{"issue":"12","key":"2021070821083838800_pnaa475-B14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.9740\/mhc.n155291","article-title":"Academic detailing: Using clinical evidence to improve care","volume":"2","author":"Popish","year":"2013","journal-title":"Ment Health Clin"},{"issue":"5","key":"2021070821083838800_pnaa475-B15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.9740\/mhc.n87507","article-title":"Fostering the use of clozapine in the severely mentally ill through academic detailing","volume":"1","author":"Farhadian","year":"2011","journal-title":"Ment Health Clin"},{"issue":"7551","key":"2021070821083838800_pnaa475-B16","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/bmj.332.7551.1207-a","article-title":"How social marketing works in health care","volume":"332","author":"Evans","year":"2006","journal-title":"Br Med J"},{"issue":"5","key":"2021070821083838800_pnaa475-B17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/0272989X08318464","article-title":"Applying social marketing in health care: Communicating evidence to change consumer behavior","volume":"28","author":"Evans","year":"2008","journal-title":"Med Decis Making"},{"issue":"1","key":"2021070821083838800_pnaa475-B18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.publhealth.26.021304.144610","article-title":"Social marketing in public health","volume":"26","author":"Grier","year":"2005","journal-title":"Annu Rev Public Health"},{"issue":"2","key":"2021070821083838800_pnaa475-B19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0749-5978(91)90020-T","article-title":"The theory of planned behavior","volume":"50","author":"Ajzen","year":"1991","journal-title":"Organ Behav Hum Decis Process"},{"key":"2021070821083838800_pnaa475-B20","volume-title":"Diffusion of Innovation","author":"Rogers","year":"1995","edition":"4th edition"},{"issue":"3","key":"2021070821083838800_pnaa475-B21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM199207163270306","article-title":"A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes","volume":"327","author":"Avorn","year":"1992","journal-title":"N Engl J Med"},{"key":"2021070821083838800_pnaa475-B22","article-title":"Academic detailing to reduce sedative-hypnotic prescribing in older veterans","author":"Ragan","year":"2019","journal-title":"J Pharm Pract"},{"key":"2021070821083838800_pnaa475-B23","doi-asserted-by":"crossref","DOI":"10.1080\/08897077.2019.1573777","article-title":"Impact of academic detailing on benzodiazepine use among veterans with posttraumatic stress disorder","author":"Bounthavong","year":"2020","journal-title":"Subst Abuse"},{"issue":"2","key":"2021070821083838800_pnaa475-B24","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.japh.2016.11.003","article-title":"Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis","volume":"57","author":"Bounthavong","year":"2017","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"2021070821083838800_pnaa475-B25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/1475-6773.13194","article-title":"Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration","volume":"54","author":"Bounthavong","year":"2019","journal-title":"Health Serv Res"},{"issue":"1","key":"2021070821083838800_pnaa475-B26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13722-016-0063-8","article-title":"Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: Interrupted time series evaluation of effectiveness","volume":"11","author":"Harris","year":"2016","journal-title":"Addict Sci Clin Pract"},{"issue":"2","key":"2021070821083838800_pnaa475-B27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J005v17n02_02","article-title":"Why program implementation is important","volume":"17","author":"Durlak","year":"1998","journal-title":"J Prev Interv Community"},{"issue":"3\u20134","key":"2021070821083838800_pnaa475-B28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10464-008-9165-0","article-title":"Implementation matters: A review of research on the influence of implementation on program outcomes and the factors affecting implementation","volume":"41","author":"Durlak","year":"2008","journal-title":"Am J Community Psychol"},{"key":"2021070821083838800_pnaa475-B29","doi-asserted-by":"crossref","first-page":"i13","DOI":"10.1136\/qshc.2008.029058","article-title":"The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: Explanation and elaboration","volume":"17(Suppl 1","author":"Ogrinc","year":"2008","journal-title":"BMJ Qual Saf"},{"key":"2021070821083838800_pnaa475-B30","year":"2020"},{"issue":"2","key":"2021070821083838800_pnaa475-B31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1744133105001210","article-title":"Effect of the implementation of an enterprise-wide Electronic Health Record on productivity in the Veterans Health Administration","volume":"1","author":"Evans","year":"2006","journal-title":"Health Econ Policy Law"},{"key":"2021070821083838800_pnaa475-B32","year":"2018"},{"key":"2021070821083838800_pnaa475-B33","year":"2014"},{"key":"2021070821083838800_pnaa475-B34","volume-title":"Negative Binomial Regression","author":"Hilbe","year":"2013","edition":"2nd edition"},{"key":"2021070821083838800_pnaa475-B35","doi-asserted-by":"crossref","DOI":"10.4135\/9781412993869","volume-title":"Fixed Effects Regression Models","author":"Allison","year":"2009","edition":"1st edition"},{"key":"2021070821083838800_pnaa475-B36","year":"2019"},{"key":"2021070821083838800_pnaa475-B37","year":"2017"},{"issue":"2","key":"2021070821083838800_pnaa475-B38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/08897077.2017.1290011","article-title":"Implementation of a pharmacy consult to reduce co-prescribing of opioids and benzodiazepines in a veteran population","volume":"38","author":"Pardo","year":"2017","journal-title":"Subst Abuse"},{"issue":"8","key":"2021070821083838800_pnaa475-B39","first-page":"e265","article-title":"Reducing coprescriptions of benzodiazepines and opioids in a veteran population","volume":"24","author":"Shayegani","year":"2018","journal-title":"Am J Manag Care"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnaa475\/36652669\/pnaa475.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/22\/6\/1426\/38490803\/pnaa475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/22\/6\/1426\/38490803\/pnaa475.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:38:35Z","timestamp":1625791115000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/22\/6\/1426\/6179644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,3,22]]},"published-print":{"date-parts":[[2021,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnaa475","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,3,22]]}}}